Skip to main content

Month: September 2020

HP Inc. Names Marie Myers as Acting Chief Financial Officer

PALO ALTO, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) today announced the appointment of Marie Myers as acting Chief Financial Officer (CFO) effective October 1, 2020. She assumes the responsibilities of Steve Fieler, who is departing for a role outside the company. HP plans to initiate a comprehensive internal and external search for a permanent successor.“As CFO since 2018, Steve has provided tremendous leadership to our financial organization and helped HP to create significant value for shareholders. He built a world-class team that is delivering strong results and I am grateful for his many contributions to our business. We wish him continued success as he begins the next chapter in his career,” said Enrique Lores, President & CEO, HP Inc.As Chief Transformation Officer, Myers currently leads the company’s...

Continue reading

Vir Biotechnology to Present at Cantor Global Virtual Healthcare Conference

SAN FRANCISCO, Sept. 09, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today announced that Phil Pang, M.D., Ph.D., chief medical officer of Vir will present at the Cantor Global Virtual Healthcare Conference on Tuesday, September 15th at 8:20 am PT/ 11:20 am ET.A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there following the presentation for 30 days.The Company has used, and intends to continue to use, the Investors page of its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor...

Continue reading

BWR Exploration Inc. Further Increases Non-Brokered Unit Offering

TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) — BWR Exploration Inc. (TSX.V: BWR) (“BWR” or the “Company”) announces that due to investor demand, it has further increased the proposed non-brokered, unit offering (the “Unit Offering”) announced on August 10 and August 19, 2020.The Unit Offering has increased to a maximum of 10,000,000 units (the “Units”) set out below at a price of $0.05 per Unit. Each Unit will consist of one common share (a “Common Share”) of the Company and one-half Common Share purchase warrant.  Two one-half Common Share purchase warrants comprise one Common Share purchase warrant (a “Full Warrant”) of the Company. Each Full Warrant will expire 36 months from the date of issue (the “Full Warrant Expiry Date”) and will entitle the holder thereof to purchase one Common Share (a “Full Warrant Share”) at a price of $0.075...

Continue reading

GameStop Reports Second Quarter Results And Strong Progress Toward Strategic Objectives

Global E-commerce Sales Increase 800%SG&A Improves by $133.7 millionGenerates Cash Flow From Operations of $192.8 million And Free Cash Flow of $181.9 millionGRAPEVINE, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) — GameStop Corp. (NYSE: GME), today reported results for the second quarter ended August 1, 2020 that reflected strong positive cash flow, a strengthened balance sheet and progress toward its strategic objectives despite the negative impact from temporary store closures related to COVID-19 and operating in the last few months of the current generation console cycle. George Sherman, GameStop’s chief executive officer, said, “The second quarter saw strong progress toward our strategic initiatives, fueling an 800% increase in global E-commerce sales, a $133.7 million reduction in SG&A and a significant improvement in...

Continue reading

BigCommerce Announces Second Quarter Financial Results

Second Quarter Total Revenue of $36.3 Million, YoY of 33%Total ARR of $151.8 Million, YoY of 32%AUSTIN, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading open SaaS ecommerce platform for fast-growing and established brands, today announced financial results for its second quarter ended June 30, 2020.“In Q2, our first quarter reported as a public company, strong execution and continued adoption of the BigCommerce platform drove total revenue growth of 33% year-over-year,” said Brent Bellm, CEO of BigCommerce. “The momentum in our business continues to strengthen and we believe our open SaaS platform – designed to deliver speed, flexibility, and innovation – best positions our merchants for the new era of ecommerce.”Second Quarter Financial HighlightsTotal revenue was $36.3...

Continue reading

Zscaler Releases New Data Protection Innovations in Zscaler Zero Trust Exchange

SAN JOSE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc., the leader in cloud security, today announced new data protection innovations in the ZscalerTM Zero Trust Exchange that protect organizations in the work-from-anywhere era by securely connecting users, devices, and applications. The Zscaler Zero Trust Exchange, built on a Secure Access Services Edge (SASE) framework, expanded its data protection capabilities with a suite of services that are now generally available. These services include Cloud Access Security Broker (CASB), Cloud Security Posture Management (CSPM) for SaaS applications, and Cloud Browser Isolation.Legacy security offerings were designed decades ago to create network based perimeters that connect people in an office to applications in a data center on a corporate network. The world was already trending...

Continue reading

Kiniksa Pharmaceuticals to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

HAMILTON, Bermuda , Sept. 09, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16th, 2020 at 2:00 p.m. Eastern Time.A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa’s website for 14 days following the conference.About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s clinical-stage product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based...

Continue reading

Paratek Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference

BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announced that the Company will present at H.C. Wainwright 22nd Annual Global Investment Conference, Monday, September 14, 2020 at 5:00 p.m. ET.To access the live webcast of Paratek’s presentation, please visit https://wsw.com/webcast/hcw7/prtk/1629433.Please connect to the web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast can be accessed for up to 90 days following the live...

Continue reading

Trillium Announces Proposed Public Offering of Common Shares

CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has commenced a public offering of up to 8,500,000 common shares (the “Common Shares”) of the Company (the “Offering”). In addition, Trillium intends to grant the underwriters a 30-day option to purchase up to an additional number of Common Shares equal to 15% of the Common Shares offered in the Offering.The Company intends to use the net proceeds of the Offering for its ongoing and planned clinical trials for its CD47 program, including drug supply and for working capital and general corporate purposes.Cowen and Evercore ISI are acting as joint book-running managers for the Offering.No...

Continue reading

Descartes Announces Fiscal 2021 Second Quarter Financial Results

Record Services Revenues and Cash Provided by Operating ActivitiesWATERLOO, Ontario, Sept. 09, 2020 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2021 second quarter (Q2FY21). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP).“The last six months have cast a spotlight on the logistics industry as an essential service,” said Edward J. Ryan, Descartes’ CEO. “Supply chain resilience and flexibility are now top-of-mind for governments and businesses alike. Technology and connectivity are central to navigating today’s dynamic landscape, helping to ensure the right goods and services are delivered to those that need them most....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.